Tayca Corporation
Form 483 issued August 25, 2023 · Okayama, Japan
- Observations
- 1
- Pages
- 2
- FEI number
- 3002777902
In short: On August 25, 2023, FDA issued a Form 483 with 1 observation to Tayca Corporation in Okayama, Okayama (FEI 3002777902). Most observations concern quality system; the most-cited regulation is 21 CFR 211.22 (responsibilities of quality control unit).
At a glance
1 of 1 observations on this 483 concern quality system.
Most cited: 21 CFR 211.22 (1×)
What FDA observed
Preview: the opening words of each observationDashed: section inferred by FDA Intel and checked against the regulation text
- 01
Procedures are not always…
This inspection in context
Questions about this 483
What did FDA find at Tayca Corporation?
FDA listed 1 observation on this Form 483, mostly about quality system. The most-cited regulation is 21 CFR 211.22 (responsibilities of quality control unit). The opening words of each observation are shown on this page.
When was Tayca Corporation inspected by FDA?
This Form 483 is dated August 25, 2023.
How do I get the full Form 483 for Tayca Corporation?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.